Robert J. Fox - Publications, H-index & Citations

Robert J. Fox

ottawa hospital research institute

65H指数

508论文数

2.3W被引数

收录论文 162

发表时间

Assessing the feasibility, theoretical interest, and observed behaviors of adding genetic data to a patient-reported multiple sclerosis registry 评估将遗传数据添加到患者报告的多发性硬化症登记系统的可行性、理论意义和观察到的行为

Multiple Sclerosis Journal-Experimental Translational and Clinical

IF2.3

2026-08-21

PREAI

Kaarina Kowalec; Douglas Menendez; Gary Cutter; Robert J Fox; Ruth Ann Marrie; Amber Salter

The gut microbiome plays a modifiable role in MS progression—No 肠道微生物组在多发性硬化症进展中发挥可调节作用—否定

Multiple Sclerosis Journal

IF5

2026-08-06

PREAI

Saira Afzal; Robert J Fox

Long-term safety and efficacy of ponesimod, an oral S1P1 receptor modulator, in relapsing-remitting multiple sclerosis (RRMS): Results from randomized phase 2b core and extension studies spanning up to 13 years 富马酸非那司提（ponesimod）在复发缓解型多发性硬化（RRMS）中的长期安全性和有效性：来自为期长达13年的随机Ⅱb期CORRE和扩展研究的成果

Multiple Sclerosis and Related Disorders

IF2.9

2026-08-01

PREAI

Olsson, Tomas; Montalban, Xavier; Hohlfeld, Reinhard; Pozzilli, Carlo; Freedman, Mark S.; Sprenger, Till; Fox, Robert J.; Havrdova, Eva Kubala; Lublin, Fred; Raghavan, Nandini; Wong, Janice; Vaclavkova, Andrea; Pirozek-Lawniczek, Magdalena; Singh, Amita; Burcklen, Michel; Kappos, Ludwig

Anti-CD20 associated enterovirus meningoencephalitis: A narrative review with two illustrative cases Anti-CD20相关的肠道病毒脑膜脑炎：一项结合两个典型案例的叙述性综述

Multiple Sclerosis Journal-Experimental Translational and Clinical

IF2.3

2026-07-28

PREAI

Kedar R Mahajan; Frank Bittner; Mary Alissa Willis; Carlos Isada; Robert Bermel; Robert J Fox; Jonathan Lee; Amy Kunchok

Bruton’s Tyrosine Kinase Inhibitors in Multiple Sclerosis 布鲁顿酪氨酸激酶抑制剂在多发性硬化症中的应用

Drugs

IF14.4

2026-05-13

OAAI

Jeffrey Lambe; Robert J. Fox

Use of semaglutide and tirzepatide among people with multiple sclerosis 塞马格鲁肽和替尔泊肽在多发性硬化症患者中的应用

Multiple Sclerosis Journal

IF5

2026-04-29

PREAI

Amber Salter; Alexis Novak; Samantha Lancia; Gary R Cutter; Robert J Fox; Ruth Ann Marrie

Safety and efficacy of opicinumab in participants with relapsing multiple sclerosis (AFFINITY Part 1): A randomized, controlled, phase 2 trial 奥匹克单抗在复发型多发性硬化患者中的安全性与有效性（AFFINITY试验第1部分）：一项随机、对照的2期临床试验

Multiple Sclerosis Journal

IF5

2025-12-26

PREAI

Peter A Calabresi; Gavin Giovannoni; Hans-Peter Hartung; Robert T Naismith; Robert J Fox; Maria Pia Sormani; Douglas L Arnold; Ludwig Kappos; Martin Valis; Scott D Newsome; Martin I Belkin; Emmanuel Bartholomé; Katherine Riester; Andrija Javor; Jennifer Lyons; Daniel P Bradley; Elizabeth Fisher; Ian Tagge; Maria L Naylor; Shibeshih Belachew; Aaron Deykin; Nathalie Franchimont; Bing Zhu; Wenting Cheng

Translating MRI advances into multiple sclerosis diagnosis: bridging science and clinical practice 将MRI进展应用于多发性硬化症诊断：连接科学与临床实践

lancet neurology

IF0

2025-09-17

PREAI

Robert J Fox; Stephen E Jones

Diffusion tensor imaging in the SPRINT-MS clinical trial: Advancing trial methodology SPRINT-MS临床 trial 中的扩散张量成像：推进试验方法学

Multiple Sclerosis Journal – Experimental, Translational and Clinical

IF0

2025-08-26

OAAI

Ken Sakaie; Mengke Du; Nancy Obuchowski; Mark J Lowe; Jian Lin; Robert J Fox

Ponesimod as add-on treatment in patients with active relapsing multiple sclerosis under dimethyl fumarate (POINT): A phase 3, randomized, placebo-controlled clinical trial Ponesimod作为添加治疗在活动性复发多发性硬化患者中的应用（POINT）：一项III期、随机、安慰剂对照临床试验

Multiple Sclerosis and Related Disorders

IF2.9

2025-07-13

PREAI

Ludwig Kappos; Michel Burcklen; Daniele D'Ambrosio; Robert J. Fox; Mark S. Freedman; Eva Kubala Havrdova; Brian Hennessy; Reinhard Hohlfeld; Anna Larbalestier; Alexandre Lemle; Ewa Lindenstrøm; Fred Lublin; Xavier Montalban; Tatiana Sidorenko; Till Sprenger; Andrea Vaclavkova; Jens Wuerfel; Carlo Pozzilli

Cognitive test performance and disease progression in primary and secondary progressive MS: An analysis of the SPRINT-MS study 认知测试表现和疾病进展在原发进展型与继发进展型多发性硬化中的比较：一项对SPRINT-MS研究的分析

MULTIPLE SCLEROSIS JOURNAL

IF5

2025-05-08

PREAI

Leavitt, Victoria M.; Fox, Robert; Mostert, Jop; D'Haeseleer, Miguel; Moral, Ester; Brieva-Ruiz, Luis; Repovic, Pavle; Bowen, James D.; Comtois, Jacynthe; Uitdehaag, Bernard; Strijbis, Eva; Cutter, Gary; Koch, Marcus W.

Safety and tolerability of conversion to siponimod from other disease-modifying therapies in patients with advancing forms of relapsing MS: Results from the EXCHANGE study 从其他疾病修正疗法转换为西尼莫德在进展型复发缓解型多发性硬化患者中的安全性与耐受性：EXCHANGE研究的结果

MULTIPLE SCLEROSIS JOURNAL

IF5

2025-04-18

PREAI

Fox, Robert J.; Cohan, Stanley; Mao-Draayer, Yang; Weinstock-Guttman, Bianca; Cruz, Linda-Ali; Arnould, Sophie; Cox, Gina Mavrikis; Bar-Or, Amit

In-vivo high-resolution t-separation at 7T 活体内高分辨率T-分离在7T

NEUROIMAGE

IF4.5

2025-03-01

OAAI

Kim, Jiye; Kim, Minjun; Ji, Sooyeon; Min, Kyeongseon; Jeong, Hwihun; Shin, Hyeong-Geol; Oh, Chungseok; Fox, Robert J.; Sakaie, Ken E.; Lowe, Mark J.; Oh, Se-Hong; Straub, Sina; Kim, Seong-Gi; Lee, Jongho

DISCOntinuation of disease-modifying therapies in MS: The DISCOMS extension trial 多发性硬化疾病修正疗法的停用：DISCOMS扩展试验

MULTIPLE SCLEROSIS JOURNAL

IF5

2025-01-21

PREAI

Corboy, John R.; Fox, Robert J.; Miller, Aaron; Morgan, Charity; Gustafson, Tarah; Goodman, Andrew D.; Kannan, Meena; Sriram, Subramanian; Xia, Zongqi; Lynch, Sharon; Bowen, James; Kister, Ilya

Access to Care and Health-Related Quality of Life in Multiple Sclerosis 在多发性硬化症中获得护理和与健康相关的生活质量

NEUROLOGY-CLINICAL PRACTICE

IF3.2

2024-12-01

PREAI

Marrie, Ruth Ann; Lancia, Samantha; Cutter, Gary R.; Fox, Robert J.; Salter, Amber

Using serum neurofilament-light in clinical practice: Growing enthusiasm that may need bridling

MULTIPLE SCLEROSIS JOURNAL

IF5

2024-10-18

OAAI

Lycke, Jan; Fox, Robert J.

Temporal Relationship Between Serum Neurofilament Light Chain and Radiologic Disease Activity in Patients With Multiple Sclerosis

NEUROLOGY

IF8.5

2024-05-14

OAAI

Fox, Robert J.; Cree, Bruce A. C.; de Seze, Jerome; Gold, Ralf; Hartung, Hans-Peter; Jeffery, Douglas; Kappos, Ludwig; Montalban, Xavier; Weinstock-Guttman, Bianca; Singh, Carol M.; Altincatal, Arman; Belviso, Nicholas; Avila, Robin L.; Ho, Pei-Ran; Su, Ray; Engle, Robert; Sangurdekar, Dipen; de Moor, Carl; Fisher, Elizabeth; Kieseier, Bernd C.; Rudick, Richard A.

Safety and Dose-Response of Vidofludimus Calcium in Relapsing Multiple Sclerosis Vidofludimus钙在复发性多发性硬化症中的安全性和剂量反应

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION

IF7.5

2024-05-01

OAAI

Fox, Robert J.; Wiendl, Heinz; Wolf, Christian; De Stefano, Nicola; Sellner, Johann; Gryb, Viktoriia; Rejdak, Konrad; Bozhinov, Plamen S.; Vitt, Daniel; Kohlhof, Hella; Slizgi, Jason; Ondrus, Matej; Sciacca, Valentina; Muehler, Andreas R.

Ibudilast reduces slowly enlarging lesions in progressive multiple sclerosis Ibudisast可减少进行性多发性硬化症中缓慢扩大的病变

MULTIPLE SCLEROSIS JOURNAL

IF5

2024-01-29

OAAI

Nakamura, Kunio; Thoomukuntla, Bhaskar; Bena, James; Cohen, Jeffrey A.; Fox, Robert J.; Ontaneda, Daniel

Serum macrophage migration inhibitory factor levels predict brain atrophy in people with primary progressive multiple sclerosis

MULTIPLE SCLEROSIS JOURNAL

IF5

2023-11-20

PREAI

Ladakis, Dimitrios C.; Reyes-Mantilla, Maria, I; Gadani, Sachin P.; Mace, Jackson W.; Dominguez-Penuela, Susana C.; Appiah, Mayaa J.; Smith, Matthew D.; Bhargava, Pavan; Fox, Robert J.; Saidha, Shiv; Calabresi, Peter A.

研究方向